“…Among strategies that have been developed to competitively interfere with the recognition processes between host cells and pathogens, multivalent glycoconjugates have the potential to prevent colonization or even reverse the formation of biofilms for fighting bacterial infection. Therefore, a large number of glycoclusters have been constructed based on various scaffolds including proteins [18,19], polymers [20,21], dendrimers [22], calixarenes [23][24][25][26][27][28][29][30][31], resorcinarenes [32], cyclodextrins [33], porphyrins [34][35][36][37], fullerenes [38][39][40][41][42][43][44][45][46][47], and pillararenes [48][49][50][51], to prevent or treat diseases caused by bacteria. Pillar[n]arenes, as a novel family of macrocyclic host molecules [52][53][54], have been well-received by the supra(bio)molecular chemistry community since their first report in 2008 by Ogoshi [55].…”